Prevalence of darunavir resistance and its use in protease inhibitor (PI)-containing regimens in the United States (2010-2015)

Trial Profile

Prevalence of darunavir resistance and its use in protease inhibitor (PI)-containing regimens in the United States (2010-2015)

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Darunavir (Primary) ; Atazanavir; Lopinavir
  • Indications HIV-1 infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Aug 2017 New trial record
    • 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top